Tyvaso and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tyvaso (treprostinil sodium) and Daliresp (roflumilast). Common drug interactions include nausea among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Tyvaso and Daliresp. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Tyvaso?

Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.



On Aug, 13, 2026

17 people who take Tyvaso and Daliresp together, and have interactions are studied.

Tyvaso and Daliresp drug interactions.

What are the common drug interactions of Tyvaso and Daliresp, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Dizziness
  3. Headache (pain in head)
  4. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  5. Dyspnoea (difficult or laboured respiration)
  6. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  7. Retching (strong involuntary effort to vomit)
  8. Acute respiratory failure
  9. Anxiety
  10. Asthenia (weakness)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Diarrhoea
  5. Discomfort
  6. Dizziness
  7. Epistaxis (bleed from the nose)
  8. Eye irritation
  9. Eye pruritus (eye itching)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Tyvaso and Daliresp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Acute respiratory failure
  2. Anxiety
  3. Asthenia (weakness)
  4. Balance disorder
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Chest pain
  8. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  9. Crying
  10. Depression

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Dizziness
  3. Epistaxis (bleed from the nose)
  4. Eye irritation
  5. Eye pruritus (eye itching)
  6. Fatigue (feeling of tiredness)
  7. Haemoglobin decreased
  8. Headache (pain in head)
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 16 people, 94.12%

* Approximation only. Some reports may have incomplete information.

Do you take Tyvaso and Daliresp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tyvaso and Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tyvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tyvaso and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daliresp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on treprostinil sodium and roflumilast (the active ingredients of Tyvaso and Daliresp, respectively), and Tyvaso and Daliresp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: